These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 5349284

  • 41. Oxidation-reduction mechanisms of cytochrome P-450.
    Miyake Y, Mori K, Yamano T.
    Biochem Biophys Res Commun; 1971 Aug 06; 44(3):564-70. PubMed ID: 4399360
    [No Abstract] [Full Text] [Related]

  • 42. Hydroxylation of aliphatic compounds by liver microsomes. II. Effect of phenobarbital induction in rats on specific activity and cytochrome P-450 substrate binding spectra.
    Frommer U, Ullrich V, Staudinger H.
    Hoppe Seylers Z Physiol Chem; 1970 Aug 06; 351(8):913-8. PubMed ID: 5451277
    [No Abstract] [Full Text] [Related]

  • 43. The inhibitory effect of metyrapone on cytochrome P-450-catalyzed mixed-function oxidation reactions as compared to the effect of carbon monoxide.
    Hildebrandt AG, Franklin MR, Roots I, Estabrook RW.
    Chem Biol Interact; 1971 Aug 06; 3(4):276-8. PubMed ID: 4399903
    [No Abstract] [Full Text] [Related]

  • 44. Effect of 1,4-dihydro-3,5-dicarbethoxycollidine on hepatic microsomal haem, cytochrome b5 and cytochrome P450 in rabbits and mice.
    Waterfield MD, Del Favero A, Gray CH.
    Biochim Biophys Acta; 1969 Jul 30; 184(2):470-3. PubMed ID: 5809730
    [No Abstract] [Full Text] [Related]

  • 45. Infrared spectral studies of carbon monoxide complexes of microsomal cytochromes P-450 and P-448.
    Böhm S, Rein H, Butschak G, Scheunig G, Billwitz H, Ruckpaul K.
    Acta Biol Med Ger; 1979 Jul 30; 38(2-3):249-55. PubMed ID: 517001
    [Abstract] [Full Text] [Related]

  • 46. A comparison of some properties of microsomal cytochrome P-450 from normal, methylcholanthrene-, and phenobarbital-treated rats.
    Imai Y, Siekevitz P.
    Arch Biochem Biophys; 1971 May 30; 144(1):143-59. PubMed ID: 5117524
    [No Abstract] [Full Text] [Related]

  • 47. [Inhibition of breakdown and increase of synthesis during phenobarbital induction of microsomal cytochromes].
    Greim H, Remmer H.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 May 30; 264(3):238-9. PubMed ID: 4242390
    [No Abstract] [Full Text] [Related]

  • 48. [Differential induction of some microsomal metabolic reactions of progesterone by treatment of rabbits with phenobarbital].
    Lange G, Thun KJ.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 May 30; 264(3):266-7. PubMed ID: 4242412
    [No Abstract] [Full Text] [Related]

  • 49. The binding of metyrapone to cytochrome P-450 and its inhibitory action on liver microsomal mixed-function oxidase reactions.
    Hildebrandt AG.
    Biochem J; 1971 Nov 30; 125(2):6P-8P. PubMed ID: 5144763
    [No Abstract] [Full Text] [Related]

  • 50. Induction by phenobarbital of hepatic microsomal drug-metabolizing enzyme system in partially hepatectomized rats.
    Hino Y, Imai Y, Sato R.
    J Biochem; 1974 Oct 30; 76(4):735-44. PubMed ID: 4436286
    [No Abstract] [Full Text] [Related]

  • 51. Rat hepatic microsomal metabolism of oxyprothepine: the role of inhibitors on S-oxygenation.
    Pauliková I, Helia O.
    Pharmazie; 1992 Jan 30; 47(1):64. PubMed ID: 1351685
    [No Abstract] [Full Text] [Related]

  • 52. The effect of metyrapone on cellular respiration and microsomal drug oxidation.
    Kahl GF, Netter KJ.
    Biochem Pharmacol; 1970 Jan 30; 19(1):27-34. PubMed ID: 5507642
    [No Abstract] [Full Text] [Related]

  • 53. The involvement of NADH-cytochrome b5 reductase and cytochrome b5 complex in microsomal NADH-cytochrome c reductase activity. Changes in NADH-cytochrome c reductase activity following phenobarbital treatment.
    Starón K, Kaniuga Z.
    Acta Biochim Pol; 1974 Jan 30; 21(1):61-6. PubMed ID: 4364831
    [No Abstract] [Full Text] [Related]

  • 54. Magnetic and spectrophotometric properties of the microsomal carbon monoxide binding pigment.
    Ichikawa Y, Hagihara B, Yamano T.
    Arch Biochem Biophys; 1967 Apr 30; 120(1):204-13. PubMed ID: 4383012
    [No Abstract] [Full Text] [Related]

  • 55. Liver microsomal metabolism of N-methylcarbazole: a probe for induction, inhibition, and species differences.
    Koop DR, Hollenberg PF.
    Mol Pharmacol; 1980 Jan 30; 17(1):118-27. PubMed ID: 7383014
    [No Abstract] [Full Text] [Related]

  • 56. The role of the hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo.
    Lieber CS, DeCarli LM.
    J Pharmacol Exp Ther; 1972 May 30; 181(2):279-87. PubMed ID: 4402282
    [No Abstract] [Full Text] [Related]

  • 57. Cytochrome P-450 ligands: metyrapone revisited.
    Liu Z, Franklin MR.
    Arch Biochem Biophys; 1985 Sep 30; 241(2):397-402. PubMed ID: 4037796
    [Abstract] [Full Text] [Related]

  • 58. Purification and partial characterization of hepatic microsomal cytochrome P-450s from phenobarbital- and 3-methylcholanthrene-treated rats.
    Masuda-Mikawa R, Fujii-Kuriyama Y, Negishi M, Tashiro Y.
    J Biochem; 1979 Nov 30; 86(5):1383-94. PubMed ID: 118169
    [Abstract] [Full Text] [Related]

  • 59. Species of cytochrome P-450 in rat liver microsomes with different stereoselectivity for the binding and monooxygenation of (+)- and (-)-methylphenobarbital.
    Bohn W, Ullrich V, Staudinger H.
    Naunyn Schmiedebergs Arch Pharmakol; 1971 Nov 30; 270(1):41-55. PubMed ID: 4253063
    [No Abstract] [Full Text] [Related]

  • 60. Spectral analysis of a solubilized hepatic cytochrome P-450 preparation for determination of contamination by cytochrome b5 and unreactive cytochrome P-450.
    Philpot RM.
    Chem Biol Interact; 1974 Sep 30; 9(3):169-80. PubMed ID: 4426106
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.